Chronic kidney disease - Is it a true risk factor of reduced clopidogrel efficacy in elderly patients with stable coronary artery disease?

Thrombosis Research

Volumn 131, Issue 3, 2013, Pages 218-224

  Leng, Wen Xiu ^a   Ren, Jun Wei ^a   Cao, Jian ^a   Cong, Yu Long ^a   Cui, Hua ^a   Hu, Guo Liang ^a   Hu, Qing Qing ^b   Niu, Hui ^c   Fan, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Outpatient Department   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Chronic kidney disease; Clopidogrel; Coronary artery disease; Creatinine clearance; Elderly; Platelet reactivity

Indexed keywords

CLOPIDOGREL; DUAL SPECIFICITY PHOSPHATASE 2; HEMOGLOBIN; PADGEM PROTEIN;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AGED, 80 AND OVER; BLOOD PLATELETS; CORONARY ARTERY DISEASE; CREATININE; FEMALE; HEMOGLOBINS; HUMANS; MALE; ODDS RATIO; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2Y12; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84875239174     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.01.008     Document Type: Article

References (32)

1. P.J. Best, R. Lennon, H.H. Ting, M.R. Bell, C.S. Rihal, and D.R. Holmes The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
2. L. Gruberg, N.J. Weissman, R. Waksman, J.R. Laird Jr., E.E. Pinnow, and H. Wu Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency Am J Cardiol 89 2002 54 57
3. R. Mehran, E. Nikolsky, A.J. Lansky, A.J. Kirtane, Y.H. Kim, and F. Feit Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: An acuity (acute catheterization and urgent intervention triage strategy) substudy JACC Cardiovasc Interv 2 2009 748 757
4. B.N. Becker, J. Himmelfarb, W.L. Henrich, and R.M. Hakim Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors J Am Soc Nephrol 8 1997 475 486
5. N. Amabile, A.P. Guerin, and A. Leroyer Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure J Am Soc Nephrol 16 2005 3381 3388
6. R.G. Luke Chronic renal failure - a vasculopathic state N Engl J Med 339 1998 841 843
7. O. Morel, S. El Ghannudi, L. Jesel, B. Radulescu, N. Meyer, and M.L. Wiesel Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired p2y12 inhibition by clopidogrel J Am Coll Cardiol 57 2011 399 408
8. Z. Motovska, D. Odvodyova, M. Fischerova, S. Stepankova, M. Maly, and P. Morawska Renal function assessed using cystatin c and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary intervention Am J Cardiol 109 2012 620 623
9. T. Cuisset, C. Frere, P.J. Moro, J. Quilici, C. Pons, and B. Gaborit Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome Thromb Res 126 2010 e400 e402
10. T.S.S. Gremmel, D. Seidinger, R. Koppensteiner, S. Panzer, and C.W. Kopp The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent Thromb Res 128 2011 352 357
11. J. Coresh, B.C. Astor, T. Greene, G. Eknoyan, and A.S. Levey Prevalence of chronic kidney disease and decreased kidney function in the adult us population: Third national health and nutrition examination survey Am J Kidney Dis 41 2003 1 12
12. L. Zhang, P. Zhang, F. Wang, L. Zuo, Y. Zhou, and Y. Shi Prevalence and factors associated with CKD: A population study from Beijing Am J Kidney Dis 51 2008 373 384
13. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, and T.A. Bass Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
14. A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, and M.W. Steffes National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
15. D.J. Angiolillo, S.B. Shoemaker, B. Desai, H. Yuan, R.K. Charlton, and E. Bernardo Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the optimizing antiplatelet therapy in diabetes mellitus (optimus) study Circulation 115 2007 708 716
16. D.J. Angiolillo, E. Bernardo, M. Sabate, P. Jimenez-Quevedo, M.A. Costa, and J. Palazuelos Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease J Am Coll Cardiol 50 2007 1541 1547
17. J. Silvain, G. Cayla, J.S. Hulot, J. Finzi, M. Kerneis, and S.A. O'Connor High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study Eur Heart J 33 2012 1241 1249
18. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Barrera Ramirez, M. Sabate, and C. Fernandez Platelet aggregation according to body mass index in patients undergoing coronary stenting: Should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16 2004 169 174
19. N. Bonello-Palot, S. Armero, F. Paganelli, J. Mancini, A. De Labriolle, and C. Bonello Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention Am J Cardiol 104 2009 1511 1515
20. D.L. Bhatt What makes platelets angry J Am Coll Cardiol 52 2008 1060 1061
21. S. Muzzarelli, and M. Pfisterer Anemia as independent predictor of major events in elderly patients with chronic angina Am Heart J 152 2006 991 996
22. G. Greenberg, A. Assali, H. Vaknin-Assa, D. Brosh, I. Teplitsky, and S. Fuchs Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction Am J Cardiol 105 2010 435 440
23. M.S. Sabatine, D.A. Morrow, R.P. Giugliano, P.B. Burton, S.A. Murphy, and C.H. McCabe Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
24. D. Tanne, N. Molshatzki, O. Merzeliak, R. Tsabari, M. Toashi, and Y. Schwammenthal Anemia status, hemoglobin concentration and outcome after acute stroke: A cohort study BMC Neurol 10 2010 22
25. C. Toma, F. Zahr, D. Moguilanski, S. Grate, R.W. Semaan, and N. Lemieux Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting Am J Cardiol 109 2012 1148 1153
26. S. Voisin, V. Bongard, M.A. Tidjane, T. Lhermusier, D. Carrie, and P. Sie Are p2y12 reaction unit (pru) and % inhibition index equivalent for the expression of p2y12 inhibition by the verifynow assay? Role of haematocrit and haemoglobin levels Thromb Haemost 106 2011 227 229
27. E. Cecchi, R. Marcucci, R. Paniccia, B. Bandinelli, S. Valente, and C. Giglioli Effect of blood hematocrit and erythrocyte deformability on adenosine 5′-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy Am J Cardiol 104 2009 764 768
28. S.H. Park, W. Kim, C.S. Park, W.Y. Kang, and S.H. Hwang A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure Am J Cardiol 104 2009 1292 1295
29. J.S. Woo, W. Kim, S.R. Lee, K.H. Jung, W.S. Kim, and J.H. Lew Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney disease (piano-2 CKD) randomized study Am Heart J 162 2011 1018 1025
30. D.J. Goldsmith, and A. Covic Coronary artery disease in uremia: Etiology, diagnosis, and therapy Kidney Int 60 2001 2059 2078
31. A.E. Kurekci, A.A. Atay, S.U. Sarici, C. Zeybek, V. Koseoglu, and O. Ozcan Effect of iron therapy on the whole blood platelet aggregation in infants with iron deficiency anemia Thromb Res 97 2000 281 285
32. U. Caliskan, A.F. Oner, N. Kabakus, and H. Koc Diminished platelet aggregation in patients with iron deficiency anemia Clin Appl Thromb Hemost 5 1999 161 163